{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T02:35:12Z","timestamp":1776479712811,"version":"3.51.2"},"reference-count":69,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"24","license":[{"start":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T00:00:00Z","timestamp":1686873600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,6,16]]},"abstract":"<jats:p>The objective of this study is to utilize bibliometric and visual analysis techniques to identify hotspots and frontiers of research in myasthenia gravis (MG) and provide valuable references for future research. The Web of Science Core Collection (WoSCC) database was used to retrieve literature data related to MG research, which was then analyzed using VOSviewer 1.6.18, CiteSpace 6.1.R3, and the Online Platform for Bibliometric Analysis. The analysis revealed 6734 publications distributed across 1612 journals and contributed by as many as 24,024 authors affiliated with 4708 institutions across 107 countries\/regions. The number of annual publications and citations for MG research has steadily increased over the past 2 decades, with the last 2 years alone witnessing a remarkable increase in annual publications and citations to over 600 and 17,000, respectively. In terms of productivity, the United States emerged as the top producing country, while the University of Oxford ranked first in terms of research institutions. Vincent A was identified as the top contributor in terms of publications and citations. <jats:italic toggle=\"yes\">Muscle &amp; Nerve<\/jats:italic> and <jats:italic toggle=\"yes\">Neurology<\/jats:italic> ranked first in publications and citations respectively, with clinical neurology and neurosciences among the main subject categories explored. The study also identified pathogenesis, eculizumab, thymic epithelial cells, immune checkpoint inhibitors, thymectomy, MuSK antibodies, risk, diagnosis, and management as the current hot research topics in MG, while burst keywords like quality of life, immune-related adverse events (irAEs), rituximab, safety, nivolumab, cancer, and classification indicated the frontiers of MG research. This study effectively identifies the hotspots and frontiers of MG research, and offers valuable references for researchers interested in this area.<\/jats:p>","DOI":"10.1097\/md.0000000000034002","type":"journal-article","created":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T18:07:44Z","timestamp":1686938864000},"page":"e34002","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":23,"title":["Global research hotspots and frontiers of myasthenia gravis from 2002 to 2021: A bibliometric study"],"prefix":"10.1097","volume":"102","author":[{"given":"Jiali","family":"Yang","sequence":"first","affiliation":[{"name":"Yancheng TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Yancheng, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaojiao","family":"Wu","sequence":"additional","affiliation":[{"name":"Xiangyu Pharmaceutical Co., Ltd., Linyi, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingliang","family":"Han","sequence":"additional","affiliation":[{"name":"Yancheng TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Yancheng, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Lu","sequence":"additional","affiliation":[{"name":"Yancheng TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Yancheng, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fangcun","family":"Li","sequence":"additional","affiliation":[{"name":"Guilin Municipal Hospital of Traditional Chinese Medicine, Guilin, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leilei","family":"Li","sequence":"additional","affiliation":[{"name":"Guangxi University of Chinese Medicine, Nanning, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaoting","family":"Su","sequence":"additional","affiliation":[{"name":"Guangxi University of Chinese Medicine, Nanning, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Jiang","sequence":"additional","affiliation":[{"name":"Shanghai University of Traditional Chinese Medicine, Shanghai, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7151-3610","authenticated-orcid":false,"given":"Zhaomeng","family":"Hou","sequence":"additional","affiliation":[{"name":"Yancheng TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Yancheng, China"},{"name":"Guangxi University of Chinese Medicine, Nanning, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1007\/s00415-016-8045-z","article-title":"Clinical features, pathogenesis, and treatment of myasthenia gravis: a supplement to the Guidelines of the German Neurological Society.","volume":"263","author":"Melzer","year":"2016","journal-title":"J Neurol"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jaut.2013.12.001","article-title":"Genetic basis of myasthenia gravis - a comprehensive review.","volume":"52","author":"Avidan","year":"2014","journal-title":"J Autoimmun"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ncl.2018.01.011","article-title":"Treatment of myasthenia gravis.","volume":"36","author":"Farmakidis","year":"2018","journal-title":"Neurol Clin"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1055\/s-0035-1558975","article-title":"Myasthenia Gravis.","volume":"35","author":"Gwathmey","year":"2015","journal-title":"Semin Neurol"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1186\/s12883-022-02833-9","article-title":"Expression of TRAF6 in peripheral blood B cells of patients with myasthenia gravis.","volume":"22","author":"Li","year":"2022","journal-title":"BMC Neurol"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"788353","DOI":"10.3389\/fped.2022.788353","article-title":"Juvenile generalized myasthenia gravis with AChR and MuSK antibody double positivity: a case report with a review of the literature.","volume":"10","author":"Ge","year":"2022","journal-title":"Front Pediatr"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1007\/s00415-022-11140-9","article-title":"Vaccines and myasthenia gravis: a comprehensive review and retrospective study of SARS-CoV-2 vaccination in a large cohort of myasthenic patients.","volume":"269","author":"Sansone","year":"2022","journal-title":"J Neurol"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"931821","DOI":"10.3389\/fimmu.2022.931821","article-title":"Herpesvirus entry mediator on T cells as a protective factor for myasthenia gravis: a Mendelian randomization study.","volume":"13","author":"Zhong","year":"2022","journal-title":"Front Immunol"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"6572","DOI":"10.1007\/s00415-022-11345-y","article-title":"Usefulness of subcutaneous immunoglobulin therapy in the management of myasthenia gravis: a retrospective cohort study.","volume":"269","author":"Barnay","year":"2022","journal-title":"J Neurol"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.3389\/fimmu.2020.01688","article-title":"Editorial: advances in autoimmune myasthenia gravis.","volume":"11","author":"Punga","year":"2020","journal-title":"Front Immunol"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/BOR.0000000000000647","article-title":"Diagnosis and treatment of myasthenia gravis.","volume":"31","author":"Mantegazza","year":"2019","journal-title":"Curr Opin Rheumatol"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1056\/NEJMra1602678","article-title":"Myasthenia gravis.","volume":"375","author":"Gilhus","year":"2016","journal-title":"N Engl J Med"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"e0273720","DOI":"10.1371\/journal.pone.0273720","article-title":"Anemia in female patients with myasthenia gravis.","volume":"17","author":"Sekiguchi","year":"2022","journal-title":"PLoS One"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"12964","DOI":"10.3390\/ijms222312964","article-title":"A review on the role of non-coding RNAs in the pathogenesis of myasthenia gravis.","volume":"22","author":"Ghafouri-Fard","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.3390\/cells11071218","article-title":"Myasthenia gravis: an acquired interferonopathy?","volume":"11","author":"Payet","year":"2022","journal-title":"Cells"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ncl.2018.01.002","article-title":"Generalized myasthenia gravis: classification, clinical presentation, natural history, and epidemiology.","volume":"36","author":"Hehir","year":"2018","journal-title":"Neurol Clin"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.3390\/nu14081647","article-title":"Exploring the gut microbiome in myasthenia gravis.","volume":"14","author":"Thye","year":"2022","journal-title":"Nutrients"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/WCO.0000000000000596","article-title":"Myasthenia gravis: from autoantibodies to therapy.","volume":"31","author":"Mantegazza","year":"2018","journal-title":"Curr Opin Neurol"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1080\/14656566.2022.2122710","article-title":"What are the pharmacotherapeutic considerations for the treatment of myasthenia gravis?","volume":"23","author":"Vanoli","year":"2022","journal-title":"Expert Opin Pharmacother"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41572-019-0079-y","article-title":"Myasthenia gravis.","volume":"5","author":"Gilhus","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/mus.26919","article-title":"Update on immune-mediated therapies for myasthenia gravis.","volume":"62","author":"Habib","year":"2020","journal-title":"Muscle Nerve"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1001\/jama.293.15.1940","article-title":"JAMA patient page. Myasthenia gravis.","volume":"293","author":"Torpy","year":"2005","journal-title":"JAMA"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s40265-022-01726-y","article-title":"Pharmacotherapy of generalized myasthenia gravis with special emphasis on newer biologicals.","volume":"82","author":"Menon","year":"2022","journal-title":"Drugs"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"690392","DOI":"10.3389\/fphar.2021.690392","article-title":"Bibliometric and visual analysis of vascular calcification research.","volume":"12","author":"Dong","year":"2021","journal-title":"Front Pharmacol"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12967-022-03293-y","article-title":"Global research trends on the links between the gut microbiome and cancer: a visualization analysis.","volume":"20","author":"Zyoud","year":"2022","journal-title":"J Transl Med"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"12644","DOI":"10.3390\/ijerph191912644","article-title":"Mapping research trends of adapted sport from 2001 to 2020: a bibliometric analysis.","volume":"19","author":"Liu","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"3742","DOI":"10.3390\/ijerph19063742","article-title":"Global trends and research hotspots in long COVID: a bibliometric analysis.","volume":"19","author":"Jin","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"R28-20250504","first-page":"242","article-title":"The methodology function of CiteSpace mapping knowledge domain.","volume":"33","author":"Chen","year":"2015","journal-title":"Stud Sci Sci"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"784705","DOI":"10.3389\/fphys.2022.784705","article-title":"Physical exercise in the context of air pollution: an emerging research topic.","volume":"13","author":"You","year":"2022","journal-title":"Front Physiol"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"697633","DOI":"10.3389\/fpubh.2021.697633","article-title":"Bibliometric review to explore emerging high-intensity interval training in health promotion: a new century picture.","volume":"9","author":"You","year":"2021","journal-title":"Front Public Health"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1016\/S0140-6736(00)05186-2","article-title":"Myasthenia gravis.","volume":"357","author":"Vincent","year":"2001","journal-title":"Lancet"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1212\/WNL.55.1.16","article-title":"Myasthenia gravis: recommendations for clinical research standards. Task force of the medical scientific advisory board of the myasthenia gravis foundation of America.","volume":"55","author":"Jaretzki","year":"2000","journal-title":"Neurology"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/85520","article-title":"Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies.","volume":"7","author":"Hoch","year":"2001","journal-title":"Nat Med"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1056\/NEJM199406233302507","article-title":"Myasthenia gravis.","volume":"330","author":"Drachman","year":"1994","journal-title":"N Engl J Med"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S1474-4422(09)70063-8","article-title":"Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity.","volume":"8","author":"Meriggioli","year":"2009","journal-title":"Lancet Neurol"},{"key":"R36-20250504","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S1474-4422(15)00145-3","article-title":"Myasthenia gravis: subgroup classification and therapeutic strategies.","volume":"14","author":"Gilhus","year":"2015","journal-title":"Lancet Neurol"},{"key":"R37-20250504","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1093\/brain\/awg223","article-title":"Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis.","volume":"126","author":"Evoli","year":"2003","journal-title":"Brain"},{"key":"R38-20250504","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1212\/WNL.26.11.1054","article-title":"Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value.","volume":"26","author":"Lindstrom","year":"1976","journal-title":"Neurology"},{"key":"R39-20250504","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1172\/JCI29894","article-title":"Myasthenia gravis: past, present, and future.","volume":"116","author":"Conti-Fine","year":"2006","journal-title":"J Clin Invest"},{"key":"R40-20250504","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1212\/WNL.0000000000002790","article-title":"International consensus guidance for management of myasthenia gravis: executive summary.","volume":"87","author":"Sanders","year":"2016","journal-title":"Neurology"},{"key":"R41-20250504","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/mus.20950","article-title":"Lifetime course of myasthenia gravis.","volume":"37","author":"Grob","year":"2008","journal-title":"Muscle Nerve"},{"key":"R42-20250504","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00415-011-6194-7","article-title":"Anti-LRP4 autoantibodies in AChR- and MuSK-antibody-negative myasthenia gravis.","volume":"259","author":"Pevzner","year":"2012","journal-title":"J Neurol"},{"key":"R43-20250504","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/ana.22312","article-title":"Autoantibodies to low-density lipoprotein receptor-related protein 4 in myasthenia gravis.","volume":"69","author":"Higuchi","year":"2011","journal-title":"Ann Neurol"},{"key":"R44-20250504","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.autrev.2013.03.001","article-title":"Pathophysiology of myasthenia gravis with antibodies to the acetylcholine receptor, muscle-specific kinase and low-density lipoprotein receptor-related protein 4.","volume":"12","author":"Verschuuren","year":"2013","journal-title":"Autoimmun Rev"},{"key":"R45-20250504","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1212\/01.WNL.0000065882.63904.53","article-title":"Clinical aspects of MuSK antibody positive seronegative MG.","volume":"60","author":"Sanders","year":"2003","journal-title":"Neurology"},{"key":"R46-20250504","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/mus.21533","article-title":"Clinical findings in MuSK-antibody positive myasthenia gravis: a U.S. experience.","volume":"41","author":"Pasnoor","year":"2010","journal-title":"Muscle Nerve"},{"key":"R47-20250504","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1093\/brain\/aws025","article-title":"Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice.","volume":"135","author":"Klooster","year":"2012","journal-title":"Brain"},{"key":"R48-20250504","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1212\/WNL.50.6.1778","article-title":"A randomized double-blind trial of prednisolone alone or with azathioprine in myasthenia gravis. Myasthenia Gravis Study Group.","volume":"50","author":"Palace","year":"1998","journal-title":"Neurology"},{"key":"R49-20250504","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1212\/01.wnl.0000312374.95186.cc","article-title":"An international, phase III, randomized trial of mycophenolate mofetil in myasthenia gravis.","volume":"71","author":"Sanders","year":"2008","journal-title":"Neurology"},{"key":"R50-20250504","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.autrev.2013.03.007","article-title":"The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes.","volume":"12","author":"Marx","year":"2013","journal-title":"Autoimmun Rev"},{"key":"R51-20250504","doi-asserted-by":"crossref","first-page":"917155","DOI":"10.3389\/fimmu.2022.917155","article-title":"Knowledge mapping of necroptosis from 2012 to 2021: a bibliometric analysis.","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Immunol"},{"key":"R52-20250504","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/s13018-022-03068-7","article-title":"Knowledge structure and emerging trends on osteonecrosis of the femoral head: a bibliometric and visualized study.","volume":"17","author":"Wu","year":"2022","journal-title":"J Orthop Surg Res"},{"key":"R53-20250504","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1056\/NEJMoa1602489","article-title":"Randomized trial of thymectomy in myasthenia gravis.","volume":"375","author":"Wolfe","year":"2016","journal-title":"N Engl J Med"},{"key":"R54-20250504","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrneurol.2016.44","article-title":"Myasthenia gravis - autoantibody characteristics and their implications for therapy.","volume":"12","author":"Gilhus","year":"2016","journal-title":"Nat Rev Neurol"},{"key":"R55-20250504","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jaut.2013.12.011","article-title":"Myasthenia gravis: a comprehensive review of immune dysregulation and etiological mechanisms.","volume":"52","author":"Berrih-Aknin","year":"2014","journal-title":"J Autoimmun"},{"key":"R56-20250504","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/mus.25597","article-title":"Rituximab treatment of myasthenia gravis: a systematic review.","volume":"56","author":"Tandan","year":"2017","journal-title":"Muscle Nerve"},{"key":"R57-20250504","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ejca.2017.05.041","article-title":"Myasthenia gravis: an emerging toxicity of immune checkpoint inhibitors.","volume":"82","author":"Makarious","year":"2017","journal-title":"Eur J Cancer"},{"key":"R58-20250504","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ejca.2016.02.024","article-title":"Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD-1 therapy.","volume":"60","author":"Zimmer","year":"2016","journal-title":"Eur J Cancer"},{"key":"R59-20250504","doi-asserted-by":"crossref","first-page":"737939","DOI":"10.3389\/fphar.2021.737939","article-title":"Mapping thematic trends and analysing hotspots concerning the use of stem cells for cartilage regeneration: a bibliometric analysis from 2010 to 2020.","volume":"12","author":"Xia","year":"2021","journal-title":"Front Pharmacol"},{"key":"R60-20250504","doi-asserted-by":"crossref","first-page":"840956","DOI":"10.3389\/fimmu.2022.840956","article-title":"A bibliometric and knowledge-map analysis of CAR-T cells from 2009 to 2021.","volume":"13","author":"Miao","year":"2022","journal-title":"Front Immunol"},{"key":"R61-20250504","doi-asserted-by":"crossref","first-page":"828299","DOI":"10.3389\/fneur.2022.828299","article-title":"Worldwide tinnitus research: a bibliometric analysis of the published literature between 2001 and 2020.","volume":"13","author":"Zhou","year":"2022","journal-title":"Front Neurol"},{"key":"R62-20250504","doi-asserted-by":"crossref","first-page":"797902","DOI":"10.3389\/fmolb.2021.797902","article-title":"Molecular mechanisms of exercise on cancer: a bibliometrics study and visualization analysis via CiteSpace.","volume":"8","author":"Zhong","year":"2021","journal-title":"Front Mol Biosci"},{"key":"R63-20250504","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1186\/s12889-023-15411-6","article-title":"Muscle quality index is associated with trouble sleeping: a cross-sectional population based study.","volume":"23","author":"You","year":"2023","journal-title":"BMC Public Health"},{"key":"R64-20250504","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3390\/brainsci13020171","article-title":"Cognitive performance in short sleep young adults with different physical activity levels: a cross-sectional fNIRS study.","volume":"13","author":"You","year":"2023","journal-title":"Brain Sci"},{"key":"R65-20250504","doi-asserted-by":"crossref","first-page":"1080782","DOI":"10.3389\/fimmu.2022.1080782","article-title":"The association between sedentary behavior, exercise, and sleep disturbance: a mediation analysis of inflammatory biomarkers.","volume":"13","author":"You","year":"2022","journal-title":"Front Immunol"},{"key":"R66-20250504","doi-asserted-by":"crossref","first-page":"717192","DOI":"10.3389\/fphar.2021.717192","article-title":"Current state and future directions of intranasal delivery route for central nervous system disorders: a scientometric and visualization analysis.","volume":"12","author":"Wu","year":"2021","journal-title":"Front Pharmacol"},{"key":"R67-20250504","doi-asserted-by":"crossref","first-page":"624534","DOI":"10.3389\/fphar.2021.624534","article-title":"Current status and trends in peptide receptor radionuclide therapy in the past 20 years (2000-2019): a bibliometric study.","volume":"12","author":"Lu","year":"2021","journal-title":"Front Pharmacol"},{"key":"R68-20250504","doi-asserted-by":"crossref","first-page":"12545","DOI":"10.3390\/ijerph191912545","article-title":"A bibliometric analysis of platelet-rich fibrin in dentistry.","volume":"19","author":"Yu","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"R69-20250504","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1186\/s12967-022-03615-0","article-title":"Global research trends and foci of artificial intelligence-based tumor pathology: a scientometric study.","volume":"20","author":"Shen","year":"2022","journal-title":"J Transl Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000034002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T01:10:14Z","timestamp":1746321014000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000034002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,16]]},"references-count":69,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000034002","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6,16]]}}}